Ampio Pharmaceuticals Coverage Initiated by Analysts at StockNews.com
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
About 55% of Ampio Pharm's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Ampio Pharm pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Ampio Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Ampio Pharm stock news signals to limit their universe of possible portfolio assets.
Ampio Pharm pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ampio daily returns and investor perception about the current price of Ampio Pharm as well as its diversification or hedging effects on your existing portfolios.
Ampio |
Equities researchers at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals in a research report issued on Saturday. The firm set a sell rating on the stock. Ampio Pharmaceuticals Stock Performance About Ampio Pharmaceuticals Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related
Read at thelincolnianonline.com
 |
Ampio Pharm Fundamental Analysis
We analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Ampio Pharm is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Ampio Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ampio Pharm pink sheet to make a market-neutral strategy. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics with similar companies.
Peers
Ampio Pharm Related Equities
| CADL | Candel Therapeutics | 4.55 | ||||
| SYBX | Synlogic | 4.17 | ||||
| ANTX | AN2 Therapeutics | 3.70 | ||||
| ZVSA | ZyVersa Therapeutics | 4.07 | ||||
| PULM | Pulmatrix | 4.31 | ||||
| ACIU | AC Immune | 4.44 | ||||
| REVB | Revelation Biosciences | 4.92 | ||||
| RNAZ | Transcode Therapeutics | 4.99 | ||||
| QNRX | Quoin Pharmaceuticals | 6.06 | ||||
| PHIO | Phio Pharmaceuticals | 6.63 | ||||
| GLUE | Monte Rosa | 8.27 | ||||
| AKTX | Akari Therapeutics | 9.22 | ||||
| ZURA | Zura Bio | 9.96 | ||||
| SONN | Sonnet Biotherapeutics | 12.92 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |